Serum-Free Medium for CD34+ Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for ex vivo expansion of hematopoietic stem cells from umbilical cord blood are limited by the need for serum and stromal cells, which can lead to immunological responses and contamination issues, and do not efficiently expand CD34+ cells to sufficient numbers for adult bone marrow reconstitution.
Innovation Solution
A stroma-free, serum-free, and chemically defined medium for mononuclear cell expansion using Iscove's modified Dulbecco's medium with bovine serum albumin, insulin, transferrin, and a cytokine formula including thrombopoietin, stem cell factor, and other growth factors, optimized through factorial design to stimulate CD34+ cell proliferation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If serum and stromal cells are used in the culture medium, then hematopoietic stem cells can be maintained, but immunological responses and contamination issues occur
Solution Approach 1:
The patent removes serum and stromal cells from the culture medium, extracting the harmful components while retaining the essential culture functions through alternative defined components. The medium uses purified growth factors and chemically defined supplements instead of complex serum-stromal cell mixtures, thereby eliminating immunological risks and contamination sources while maintaining stem cell viability and expansion capabilities.
2Ease of manufacture
If conventional culture methods are used, then cell culture can be performed, but CD34+ cells do not expand to sufficient numbers for adult bone marrow reconstitution
Solution Approach 1:
The patent optimizes specific parameters of the culture medium including precise concentrations of growth factors (SCF, TPO, FL, IL-3, IL-6, G-CSF, GM-CSF), serum substitute composition (BSA, insulin, transferrin), and basal medium formulation. These parameter changes create optimal conditions for CD34+ cell proliferation, enabling expansion to therapeutic levels suitable for adult bone marrow reconstitution while maintaining cell quality and differentiation potential.
3Reliability
If CD34+ cell isolation is performed, then pure stem cells can be obtained, but costs increase and processing time is extended
Solution Approach 1:
The patent enables the culture medium itself to selectively support and expand CD34+ cells from the mixed mononuclear cell population without requiring prior isolation. The defined growth factor composition and serum substitute create a selective environment where CD34+ cells proliferate preferentially, allowing direct culture of umbilical cord blood mononuclear cells and achieving both purity and efficiency without additional isolation steps.
Data Source
AI summary
A stroma-free, serum-free, and chemically defined medium and a method for mononuclear cell expansion ex vivo using the same. An exemplary medium includes a basal medium, a serum substitute, and a cytokine formula.